Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease
1. The biosimilar to infliximab, CT-P13 was shown in this study to have equivalent efficacy to the anti tumor-necrosis factor...
1. The biosimilar to infliximab, CT-P13 was shown in this study to have equivalent efficacy to the anti tumor-necrosis factor...
1. This study showed that the net benefit of statins compared to risk varied considerably with respect to the age...
1. The results of this study suggested that the prevalence of atopic dermatitis increased with age among a U.K. adult...
1. Researchers have identified a significant increase in hospitalizations due to infective endocarditis related to drug use. 2. Heart valve...
1. A significant reduction in major cardiac events among elderly patients was seen in the liraglutide treatment group. 2. The risk...
1. This secondary analysis of genetic data emphasized the high number of potentially “pathogenic” variants that are revealed through exome...
1. This ten-year follow-up study of a randomized controlled trial suggested that intradermal administration of one fifth of the yellow...
1. The authors of this study generated four principles to identify the role of patients and families in developing physicians’...
1. In a case-report, 41-year-old patient requiring intubation for respiratory failure due to status asthmaticus clinically improved after administration of...
1. In this study, no significant differences were seen in the diabetes outcomes of patients managed by nurse practitioners (NPs)...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.